LGALS3 Human (+)-schisandrin B multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:31150632 LGALS3 Human (1->4)-beta-D-glucan multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 LGALS3 Human 1,1-dichloroethene increases expression ISO Lgals3 (Mus musculus) 6480464 vinylidene chloride results in increased expression of LGALS3 mRNA CTD PMID:26682919 LGALS3 Human 1,4-dichlorobenzene increases expression ISO Lgals3 (Mus musculus) 6480464 4-dichlorobenzene results in increased expression of LGALS3 mRNA CTD PMID:26975756 LGALS3 Human 1-naphthyl isothiocyanate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA CTD PMID:17522070 more ... LGALS3 Human 17alpha-ethynylestradiol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of LGALS3 mRNA CTD PMID:17557909 LGALS3 Human 17beta-estradiol affects expression ISO Lgals3 (Mus musculus) 6480464 Estradiol affects the expression of LGALS3 mRNA CTD PMID:15598610 LGALS3 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA and [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 and PMID:20823114 LGALS3 Human 17beta-estradiol increases expression ISO Lgals3 (Mus musculus) 6480464 Estradiol results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA CTD PMID:20159946 LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:17035482 more ... LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:11489354 more ... LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:21570461 more ... LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:20959002 more ... LGALS3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:22298810 and PMID:34747641 LGALS3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:26705709 LGALS3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Lgals3 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 LGALS3 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 LGALS3 Human 2-nitrofluorene increases expression ISO Lgals3 (Rattus norvegicus) 6480464 2-nitrofluorene results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Lgals3 (Rattus norvegicus) 6480464 3 more ... CTD PMID:20959002 LGALS3 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 LGALS3 Human 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of LGALS3 protein CTD PMID:31675489 LGALS3 Human 3-chloropropane-1,2-diol decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA CTD PMID:28522335 LGALS3 Human 3-chloropropane-1,2-diol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of LGALS3 protein CTD PMID:34915118 LGALS3 Human 3-methylcholanthrene increases expression ISO Lgals3 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of LGALS3 mRNA CTD PMID:20713471 LGALS3 Human 3H-1,2-dithiole-3-thione decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of LGALS3 mRNA CTD PMID:19162173 LGALS3 Human 4,4'-diaminodiphenylmethane increases expression ISO Lgals3 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA CTD PMID:25380136 LGALS3 Human 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of LGALS3 mRNA CTD PMID:25912373 LGALS3 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of LGALS3 protein CTD PMID:34186270 LGALS3 Human 4,4'-sulfonyldiphenol decreases methylation ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in decreased methylation of LGALS3 exon CTD PMID:33297965 LGALS3 Human 4,4'-sulfonyldiphenol increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol S results in increased expression of LGALS3 mRNA CTD PMID:30951980 LGALS3 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Lgals3 (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human 4-hydroxyphenyl retinamide decreases expression ISO Lgals3 (Mus musculus) 6480464 Fenretinide results in decreased expression of LGALS3 mRNA CTD PMID:28973697 LGALS3 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of LGALS3 mRNA CTD PMID:19194470 LGALS3 Human 5-fluorouracil affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 LGALS3 Human 5-fluorouracil multiple interactions ISO Lgals3 (Rattus norvegicus) 150530464 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD LGALS3 Human 5-fluorouracil decreases response to substance EXP 6480464 LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil CTD PMID:21750908 LGALS3 Human 6-propyl-2-thiouracil increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of LGALS3 mRNA CTD PMID:24780913 LGALS3 Human 7,12-dimethyltetraphene affects expression ISO Lgals3 (Mus musculus) 6480464 9 more ... CTD PMID:21785161 LGALS3 Human acetamide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 acetamide results in increased expression of LGALS3 mRNA CTD PMID:31881176 LGALS3 Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein and Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 and PMID:38460933 LGALS3 Human aflatoxin B1 increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:27153756 LGALS3 Human aflatoxin B1 decreases expression ISO Lgals3 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of LGALS3 mRNA CTD PMID:19770486 LGALS3 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:12875902 LGALS3 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LGALS3 mRNA CTD PMID:23724009 LGALS3 Human all-trans-retinoic acid decreases expression ISO Lgals3 (Mus musculus) 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:16604517 LGALS3 Human ammonium chloride affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of LGALS3 mRNA CTD PMID:16483693 LGALS3 Human amphetamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of LGALS3 mRNA CTD PMID:30779732 LGALS3 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of LGALS3 protein CTD PMID:33212167 LGALS3 Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to LGALS3 protein] and arsenite promotes the reaction [G3BP1 protein binds to LGALS3 mRNA] CTD PMID:32406909 LGALS3 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 LGALS3 Human benzo[a]pyrene increases expression ISO Lgals3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA CTD PMID:22228805 and PMID:23735875 LGALS3 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of LGALS3 promoter CTD PMID:27901495 LGALS3 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of LGALS3 5' UTR CTD PMID:27901495 LGALS3 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA and Benzo(a)pyrene results in increased expression of LGALS3 protein CTD PMID:16269432 more ... LGALS3 Human benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of LGALS3 mRNA CTD PMID:16269432 LGALS3 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of LGALS3 mRNA CTD PMID:38218311 LGALS3 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of LGALS3 mRNA CTD PMID:19737606 LGALS3 Human bexarotene decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 bexarotene results in decreased expression of LGALS3 mRNA CTD PMID:16648578 LGALS3 Human bezafibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Bezafibrate results in increased expression of LGALS3 mRNA CTD PMID:17118139 LGALS3 Human bis(2-chloroethyl) sulfide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Mustard Gas results in increased expression of LGALS3 protein CTD PMID:33002157 LGALS3 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of LGALS3 mRNA CTD PMID:31163220 LGALS3 Human bisphenol A increases expression ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of LGALS3 mRNA CTD PMID:25181051 LGALS3 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LGALS3 protein CTD PMID:34186270 LGALS3 Human bisphenol A affects expression ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:32145629 LGALS3 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS3 protein CTD PMID:33376534 and PMID:37567409 LGALS3 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:30903817 LGALS3 Human bisphenol A increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of LGALS3 gene CTD PMID:28505145 LGALS3 Human bisphenol F increases expression ISO Lgals3 (Mus musculus) 6480464 bisphenol F results in increased expression of LGALS3 mRNA CTD PMID:30951980 LGALS3 Human bleomycin A2 multiple interactions ISO Lgals3 (Mus musculus) 6480464 NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] CTD PMID:26526764 LGALS3 Human bleomycin A2 increases expression ISO Lgals3 (Mus musculus) 6480464 Bleomycin results in increased expression of LGALS3 protein CTD PMID:26526764 LGALS3 Human bucladesine multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 LGALS3 Human buspirone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Buspirone results in decreased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human cadmium dichloride affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of LGALS3 mRNA CTD PMID:22110744 LGALS3 Human cadmium dichloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of LGALS3 mRNA CTD PMID:25993096 LGALS3 Human calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of LGALS3 mRNA CTD PMID:12875902 LGALS3 Human calyculin a increases expression ISO Lgals3 (Mus musculus) 6480464 calyculin A results in increased expression of LGALS3 mRNA CTD PMID:25270620 LGALS3 Human carbon nanotube affects expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of LGALS3 mRNA CTD PMID:23845593 LGALS3 Human carbon nanotube increases expression ISO Lgals3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:27106021 LGALS3 Human cefaloridine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cephaloridine results in increased expression of LGALS3 mRNA CTD PMID:18500788 LGALS3 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to LGALS3 gene] CTD PMID:28238834 LGALS3 Human chloroform increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Chloroform results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human choline multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 LGALS3 Human ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA CTD PMID:16197558 LGALS3 Human cisplatin multiple interactions EXP 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21368866 and PMID:21821001 LGALS3 Human cisplatin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [citrus pectin co-treated with Cisplatin] results in increased localization of LGALS3 protein CTD PMID:38522819 LGALS3 Human cisplatin decreases response to substance EXP 6480464 GAL3 protein results in decreased susceptibility to Cisplatin more ... CTD PMID:21368866 more ... LGALS3 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of LGALS3 mRNA and Cisplatin results in increased expression of LGALS3 protein CTD PMID:21821001 and PMID:27392435 LGALS3 Human clofibrate increases expression ISO Lgals3 (Mus musculus) 6480464 Clofibrate results in increased expression of LGALS3 mRNA CTD PMID:17585979 LGALS3 Human cobalt dichloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of LGALS3 mRNA CTD PMID:24386269 LGALS3 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of LGALS3 mRNA CTD PMID:19549813 LGALS3 Human Cuprizon increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of LGALS3 mRNA CTD PMID:26577399 and PMID:27523638 LGALS3 Human cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 LGALS3 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of LGALS3 mRNA CTD PMID:25562108 and PMID:27989131 LGALS3 Human decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of LGALS3 protein CTD PMID:31675489 LGALS3 Human dexamethasone multiple interactions EXP 6480464 [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein CTD PMID:16166312 LGALS3 Human dexamethasone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 LGALS3 Human dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:16269432 LGALS3 Human dibenzo[a,l]pyrene increases expression EXP 6480464 dibenzo(a and l)pyrene results in increased expression of LGALS3 protein CTD PMID:18495319 LGALS3 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of LGALS3 mRNA CTD PMID:37042841 LGALS3 Human diclofenac increases expression ISO Lgals3 (Mus musculus) 6480464 Diclofenac results in increased expression of LGALS3 mRNA CTD PMID:26934552 LGALS3 Human dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of LGALS3 mRNA CTD PMID:28302478 LGALS3 Human diethylstilbestrol increases expression ISO Lgals3 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human diethylstilbestrol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human dimethylarsinic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of LGALS3 mRNA CTD PMID:16122865 LGALS3 Human dioxygen increases expression ISO Lgals3 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of LGALS3 mRNA CTD PMID:17193925 LGALS3 Human dioxygen multiple interactions ISO Lgals3 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA and [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of LGALS3 mRNA CTD PMID:19640911 and PMID:30529165 LGALS3 Human dioxygen increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Oxygen deficiency results in increased expression of LGALS3 protein and Oxygen results in increased expression of LGALS3 mRNA CTD PMID:22911455 and PMID:32003113 LGALS3 Human diquat increases expression ISO Lgals3 (Mus musculus) 6480464 Diquat results in increased expression of LGALS3 mRNA CTD PMID:36851058 LGALS3 Human diuron increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diuron results in increased expression of LGALS3 mRNA CTD PMID:21551480 LGALS3 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 LGALS3 Human doxorubicin decreases response to substance EXP 6480464 LGALS3 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 LGALS3 Human doxorubicin increases expression ISO Lgals3 (Mus musculus) 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:36227756 LGALS3 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:29803840 LGALS3 Human endosulfan increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of LGALS3 mRNA CTD PMID:29391264 LGALS3 Human entinostat increases expression EXP 6480464 entinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human erythromycin estolate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Erythromycin Estolate results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human etoposide affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Etoposide CTD PMID:16217747 LGALS3 Human fenamidone increases expression ISO Lgals3 (Mus musculus) 6480464 fenamidone results in increased expression of LGALS3 mRNA CTD PMID:27029645 LGALS3 Human ferric oxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 ferric oxide analog results in increased expression of LGALS3 mRNA CTD PMID:38615722 LGALS3 Human flurbiprofen increases expression ISO Lgals3 (Mus musculus) 6480464 Flurbiprofen results in increased expression of LGALS3 mRNA CTD PMID:16949054 LGALS3 Human folic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Folic Acid results in increased expression of LGALS3 mRNA CTD PMID:10980121 LGALS3 Human folic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 LGALS3 Human genistein increases expression ISO Lgals3 (Mus musculus) 6480464 Genistein results in increased expression of LGALS3 mRNA CTD PMID:15289156 LGALS3 Human gentamycin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of LGALS3 mRNA CTD PMID:33387578 LGALS3 Human glafenine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Glafenine results in increased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human isoprenaline increases expression ISO Lgals3 (Mus musculus) 6480464 Isoproterenol results in increased expression of LGALS3 mRNA CTD PMID:20003209 LGALS3 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of LGALS3 protein CTD PMID:32959892 LGALS3 Human L-ascorbic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ascorbic Acid results in increased expression of LGALS3 mRNA CTD PMID:15372504 LGALS3 Human L-methionine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 LGALS3 Human lactose affects binding EXP 6480464 Lactose binds to LGALS3 protein CTD PMID:17385862 LGALS3 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of LGALS3 mRNA CTD PMID:28988120 and PMID:29427785 LGALS3 Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein more ... CTD PMID:21821001 LGALS3 Human LY294002 decreases response to substance EXP 6480464 LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one CTD PMID:21821001 LGALS3 Human manganese(II) chloride increases expression ISO Lgals3 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of LGALS3 mRNA CTD PMID:28801915 LGALS3 Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 LGALS3 Human mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human methapyrilene increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human methimazole increases expression EXP 6480464 Methimazole results in increased expression of LGALS3 mRNA CTD PMID:20144635 LGALS3 Human methoxychlor increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 Methoxychlor results in increased methylation of LGALS3 gene CTD PMID:23303685 LGALS3 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of LGALS3 mRNA CTD PMID:23179753 and PMID:34089799 LGALS3 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of LGALS3 mRNA CTD PMID:28001369 LGALS3 Human microcystin-LR increases expression ISO Lgals3 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of LGALS3 mRNA CTD PMID:17654400 LGALS3 Human mifepristone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Mifepristone results in decreased expression of LGALS3 mRNA CTD PMID:25972201 LGALS3 Human mitomycin C affects response to substance EXP 6480464 LGALS3 protein affects the susceptibility to Mitomycin CTD PMID:16217747 LGALS3 Human monocrotaline multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein] more ... CTD PMID:27870162 LGALS3 Human N,N-diethyl-m-toluamide multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 LGALS3 Human N-acetylsphingosine increases expression EXP 6480464 N-acetylsphingosine results in increased expression of LGALS3 protein CTD PMID:21821001 LGALS3 Human N-acetylsphingosine decreases response to substance EXP 6480464 LGALS3 results in decreased susceptibility to N-acetylsphingosine CTD PMID:21821001 LGALS3 Human N-acetylsphingosine multiple interactions EXP 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21821001 LGALS3 Human N-ethyl-N-nitrosourea increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ethylnitrosourea results in increased expression of LGALS3 mRNA CTD PMID:15954086 LGALS3 Human N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 LGALS3 Human N-methyl-N-nitrosourea decreases expression ISO Lgals3 (Mus musculus) 6480464 Methylnitrosourea results in decreased expression of LGALS3 mRNA CTD PMID:25270620 LGALS3 Human N-methyl-N-nitrosourea increases expression ISO Lgals3 (Rattus norvegicus) 150530464 N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum RGD LGALS3 Human N-nitrosodiethylamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:19638242 LGALS3 Human N-nitrosodiethylamine multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 LGALS3 Human N-nitrosodiethylamine multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA CTD PMID:24535843 LGALS3 Human N-nitrosodimethylamine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:15890375 and PMID:25380136 LGALS3 Human N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:17547211 LGALS3 Human N-nitrosomorpholine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of LGALS3 mRNA CTD PMID:19716841 LGALS3 Human naloxone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Naloxone results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human nickel atom increases expression ISO Lgals3 (Mus musculus) 6480464 Nickel results in increased expression of LGALS3 mRNA CTD PMID:12540486 LGALS3 Human nickel subsulfide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 nickel subsulfide results in increased expression of LGALS3 mRNA CTD PMID:21086188 LGALS3 Human nickel sulfate affects expression ISO Lgals3 (Mus musculus) 6480464 nickel sulfate affects the expression of LGALS3 mRNA CTD PMID:12718980 LGALS3 Human nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of LGALS3 mRNA CTD PMID:18651567 LGALS3 Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of LGALS3 mRNA CTD PMID:36318118 LGALS3 Human Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of LGALS3 protein CTD PMID:16054331 LGALS3 Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein CTD PMID:38460933 LGALS3 Human ochratoxin A increases expression ISO Lgals3 (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of LGALS3 mRNA CTD PMID:38301995 LGALS3 Human oxycodone decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Oxycodone results in decreased expression of LGALS3 mRNA CTD PMID:23439660 LGALS3 Human ozone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Ozone results in increased expression of LGALS3 protein CTD PMID:22727909 LGALS3 Human ozone multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LGALS3 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LGALS3 mRNA CTD PMID:34911549 LGALS3 Human panobinostat increases expression EXP 6480464 panobinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human paracetamol affects expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen affects the expression of LGALS3 mRNA CTD PMID:17562736 LGALS3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LGALS3 mRNA CTD PMID:26690555 LGALS3 Human paracetamol affects response to substance ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the susceptibility to Acetaminophen CTD PMID:22461450 LGALS3 Human paracetamol multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA] more ... CTD PMID:22461450 LGALS3 Human paracetamol increases expression ISO Lgals3 (Mus musculus) 6480464 Acetaminophen results in increased expression of LGALS3 mRNA and Acetaminophen results in increased expression of LGALS3 protein CTD PMID:22461450 and PMID:34724096 LGALS3 Human paraquat increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Paraquat results in increased expression of LGALS3 mRNA and Paraquat results in increased expression of LGALS3 protein CTD PMID:24521700 and PMID:32680482 LGALS3 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Lgals3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA CTD PMID:36331819 LGALS3 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of LGALS3 protein CTD PMID:26879310 LGALS3 Human permethrin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene CTD PMID:33148267 LGALS3 Human phenacetin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Phenacetin results in increased expression of LGALS3 mRNA CTD PMID:17082564 and PMID:17698508 LGALS3 Human phenobarbital multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LGALS3 mRNA] CTD PMID:19482888 and PMID:24535843 LGALS3 Human phenobarbital increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19162173 LGALS3 Human phenobarbital increases expression ISO Lgals3 (Mus musculus) 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19482888 LGALS3 Human phenylhydrazine increases expression ISO Lgals3 (Rattus norvegicus) 6480464 phenylhydrazine results in increased expression of LGALS3 mRNA CTD PMID:17082564 and PMID:17698508 LGALS3 Human phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human phorbol 13-acetate 12-myristate multiple interactions ISO Lgals3 (Mus musculus) 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 LGALS3 Human phosgene affects expression ISO Lgals3 (Mus musculus) 6480464 Phosgene affects the expression of LGALS3 mRNA CTD PMID:16300373 LGALS3 Human piperonyl butoxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Piperonyl Butoxide results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS3 mRNA CTD PMID:19710929 LGALS3 Human pirinixic acid increases expression ISO Lgals3 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:15890375 LGALS3 Human pirinixic acid increases expression ISO Lgals3 (Mus musculus) 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:17118139 LGALS3 Human potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of LGALS3 protein CTD PMID:23718831 LGALS3 Human progesterone affects metabolic processing ISO Lgals3 (Mus musculus) 6480464 LGALS3 protein affects the metabolism of Progesterone CTD PMID:17242467 LGALS3 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 LGALS3 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of LGALS3 mRNA CTD PMID:21632981 LGALS3 Human quercetin multiple interactions ISO Lgals3 (Rattus norvegicus) 150530464 Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] RGD LGALS3 Human quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of LGALS3 mRNA CTD PMID:21632981 LGALS3 Human quinoline increases expression EXP 6480464 quinoline analog results in increased expression of LGALS3 protein CTD PMID:18645022 LGALS3 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 LGALS3 Human reactive oxygen species increases abundance EXP 6480464 LGALS3 protein results in increased abundance of Reactive Oxygen Species CTD PMID:34894372 LGALS3 Human resveratrol increases expression ISO Lgals3 (Rattus norvegicus) 6480464 resveratrol results in increased expression of LGALS3 mRNA CTD PMID:25905778 LGALS3 Human resveratrol multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA CTD PMID:25905778 LGALS3 Human rotenone increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Rotenone results in increased expression of LGALS3 mRNA CTD PMID:27900601 LGALS3 Human S-(1,2-dichlorovinyl)-L-cysteine decreases expression EXP 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of LGALS3 mRNA CTD PMID:36336211 and PMID:37544576 LGALS3 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 LGALS3 Human silicon dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA and Silicon Dioxide results in increased expression of LGALS3 protein CTD PMID:23221170 more ... LGALS3 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LGALS3 protein CTD PMID:36223831 LGALS3 Human silicon dioxide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA CTD PMID:21602193 and PMID:22431001 LGALS3 Human sodium arsenite decreases expression ISO Lgals3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of LGALS3 protein CTD PMID:29044176 LGALS3 Human sodium dichromate increases expression ISO Lgals3 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of LGALS3 mRNA CTD PMID:25993096 LGALS3 Human sodium fluoride decreases expression ISO Lgals3 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of LGALS3 protein CTD PMID:28918527 LGALS3 Human streptozocin multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA and vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 and PMID:25905778 LGALS3 Human streptozocin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of LGALS3 mRNA CTD PMID:16684804 LGALS3 Human sulindac multiple interactions EXP 6480464 Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] CTD PMID:15190207 LGALS3 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of LGALS3 mRNA CTD PMID:31533062 LGALS3 Human tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of LGALS3 mRNA CTD PMID:14699072 LGALS3 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of LGALS3 mRNA CTD PMID:31758290 LGALS3 Human testosterone increases expression ISO Lgals3 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of LGALS3 mRNA CTD PMID:33848595 LGALS3 Human testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of LGALS3 mRNA CTD PMID:33359661 LGALS3 Human tetrachloromethane increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:12629582 more ... LGALS3 Human tetrachloromethane decreases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of LGALS3 protein CTD PMID:29044176 LGALS3 Human tetrachloromethane multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter] and schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:16309856 and PMID:31150632 LGALS3 Human tetrachloromethane affects expression ISO Lgals3 (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:12734012 LGALS3 Human tetrachloromethane multiple interactions ISO Lgals3 (Mus musculus) 6480464 LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] more ... CTD PMID:16549783 and PMID:23798564 LGALS3 Human tetrachloromethane affects expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:17484886 LGALS3 Human tetrachloromethane increases expression ISO Lgals3 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:16549783 more ... LGALS3 Human tetracycline increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Tetracycline results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human theophylline increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Theophylline results in increased expression of LGALS3 mRNA CTD PMID:17522070 LGALS3 Human thioacetamide multiple interactions ISO Lgals3 (Mus musculus) 6480464 MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] CTD PMID:23798564 LGALS3 Human thioacetamide increases expression ISO Lgals3 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:34492290 LGALS3 Human thioacetamide multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 LGALS3 Human thioacetamide increases expression ISO Lgals3 (Mus musculus) 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:23798564 LGALS3 Human titanium dioxide increases expression ISO Lgals3 (Mus musculus) 6480464 titanium dioxide results in increased expression of LGALS3 mRNA CTD PMID:23557971 and PMID:27760801 LGALS3 Human titanium dioxide decreases methylation ISO Lgals3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of LGALS3 gene CTD PMID:35295148 LGALS3 Human tremolite asbestos increases expression ISO Lgals3 (Mus musculus) 6480464 tremolite results in increased expression of LGALS3 mRNA CTD PMID:29279043 LGALS3 Human trichloroethene increases methylation ISO Lgals3 (Rattus norvegicus) 6480464 Trichloroethylene results in increased methylation of LGALS3 gene CTD PMID:27618143 LGALS3 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of LGALS3 mRNA CTD PMID:24935251 and PMID:26272509 LGALS3 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of LGALS3 mRNA CTD PMID:30510588 LGALS3 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of LGALS3 mRNA CTD PMID:37042841 LGALS3 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA CTD PMID:29024780 LGALS3 Human tungsten decreases expression ISO Lgals3 (Mus musculus) 6480464 Tungsten results in decreased expression of LGALS3 mRNA CTD PMID:30912803 LGALS3 Human tunicamycin increases expression ISO Lgals3 (Mus musculus) 6480464 Tunicamycin results in increased expression of LGALS3 mRNA CTD PMID:17127020 LGALS3 Human valdecoxib increases expression ISO Lgals3 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of LGALS3 mRNA CTD PMID:24136188 LGALS3 Human valproic acid affects expression ISO Lgals3 (Mus musculus) 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:17963808 LGALS3 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of LGALS3 mRNA CTD PMID:19101580 more ... LGALS3 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:25979313 LGALS3 Human vanadyl sulfate multiple interactions ISO Lgals3 (Rattus norvegicus) 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 LGALS3 Human vancomycin decreases expression ISO Lgals3 (Mus musculus) 6480464 Vancomycin results in decreased expression of LGALS3 mRNA CTD PMID:18930951 LGALS3 Human vinclozolin affects expression ISO Lgals3 (Rattus norvegicus) 6480464 vinclozolin affects the expression of LGALS3 mRNA CTD PMID:19015723 LGALS3 Human vinclozolin increases expression ISO Lgals3 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of LGALS3 mRNA CTD PMID:23034163 LGALS3 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 LGALS3 Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 LGALS3 Human zinc oxide decreases expression ISO Lgals3 (Rattus norvegicus) 6480464 Zinc Oxide results in decreased expression of LGALS3 protein CTD PMID:33205376